Photo Credit: Dave Center

Domino’s Pizza Inc. (DPZ) Releasing 7/25/17 BMO

The Estimize consensus calls for EPS of $1.25, three cents higher than the Wall Street consensus. Currently, the Estimize community is looking for revenues of $616.35M, just slightly higher than the Street’s expectation for $609.58M.

Domino’s is showing some impressive numbers this quarter, with a P/E ratio of 45.73 and a dividend yield of 0.86%. Likewise, the Estimize community is showing positive numbers for YoY growth for both EPS and Revenue, 28% and 13%, respectively. Last quarter, DPZ saw a negative return on equity of 12.21% and a net margin of 9.06%. Despite Domino’s’ simple food products, they focus their resources on elaborate marketing strategies and cross company collaborations. For example, they are introducing a “pizza theater” store front to make picking up your pizza the ultimate experience, as well as partnering with Twitter for an e-commerce wedding registry to order Domino’s for your bachelor/bachelorette parties and/or guests.

AT&T Inc. (T) Releasing 7/25/17 AMC

The Estimize consensus calls for EPS of $1.25, three cents higher than the Wall Street consensus. Currently, the Estimize community is looking for revenues of $616.35M, just slightly higher than the Street’s expectation for $609.58M.

AT&T is displaying a strong dividend yield of 5.4% but other problems such as competition from wireless networks and controversy over a potential merger may drive the stock downwards. Other wireless providers such as T-Mobile and Sprint have cleaned up their act and have taken some shares from AT&T. T-Mobile is also showing strong numbers for Q2, something analysts think is a result from previous AT&T customers going to T-Mobile instead. Moreover, AT&T has been in talks with CNN and HBO for a potential merger. Media and pay-TV corporations have presented this to the justice department is a problem because this merger would favor in house programming. Even President Trump chimed in and said that this merger would further concentrate media power.

JetBlue Airways Corporation (JBLU) Releasing 7/25/17 BMO

The Estimize consensus calls for EPS of $0.55, even with the Wall Street consensus. Currently, the Estimize community is looking for revenues of $1.810B, just slightly lower than the Street’s expectation for $1.815B.

Interesting things are happening for JBLU, something tristaters would specifically like to consider. The airline company is in talks to build a new terminal at JFK that would increase capacity, better the clients’ experiences, and allow for partnerships with more airlines, as well as a $10 billion revamp of JFK. Currently, JetBlue operates out of Terminal 5, but they are proposing to expand to Terminal 6 and connect the two. JBLU is predicted to show YoY earnings growth of 4% and revenue growth of 10%.

Biogen Inc (BIIB) Releasing 7/25/17 BMO

The Estimize consensus calls for EPS of $4.60, slightly higher than the Wall Street’s consensus of $4.40. Currently, the Estimize community is looking for revenues of $2.826B, just slightly higher than the Street’s expectation for $2.812B.

There are interesting things happening for Biogen’s spinal muscular atrophy drug, Spiranza. Recently the company released that they made $47m in sales and $10m in inventory build. Likewise, there is a 5% increase in shares since the beginning of the year. Despite this, the biotech industry, in general, has been under pressure and is expected to be one of the laggards in the health care industry this quarter. Even Biogen is estimated to see YoY EPS growth fall 11% and revenues decrease by 2%.